Sofinnova Partners (“Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Biovelocita II. The fund has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback